Pfizer seeking new ruling on patent by China

Pfizer is continuing to lobby China's State Intellectual Property Office to get back its patent for Viagra. The company is asking the department to reconsider its decision overturning the Viagra patent and faces an Oct. 5 deadline for appealing the decision. A company official said Pfizer is "hopeful and cautiously optimistic" the Chinese agency will allow the decision to be appealed.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC